Table1_The adenosine A2A receptor antagonist KW6002 distinctly regulates retinal ganglion cell morphology during postnatal development and neonatal inflammation.XLSX by Shisi Hu (14267858)

“…We found that the A_2AR antagonist KW6002 did not change the proportion of the three RGC types during retinal development, but exerted a bidirectional effect on dendritic complexity of Type I and III RGCs and cell type-specifically altered their morphologies with decreased dendrite density of Type I, decreased the dendritic field area of Type II and III, increased dendrite density of Type III RGCs. …”

DataSheet1_The adenosine A2A receptor antagonist KW6002 distinctly regulates retinal ganglion cell morphology during postnatal development and neonatal inflammation.PDF by Shisi Hu (14267858)

“…We found that the A_2AR antagonist KW6002 did not change the proportion of the three RGC types during retinal development, but exerted a bidirectional effect on dendritic complexity of Type I and III RGCs and cell type-specifically altered their morphologies with decreased dendrite density of Type I, decreased the dendritic field area of Type II and III, increased dendrite density of Type III RGCs. …”

Table2_The adenosine A2A receptor antagonist KW6002 distinctly regulates retinal ganglion cell morphology during postnatal development and neonatal inflammation.XLSX by Shisi Hu (14267858)

“…We found that the A_2AR antagonist KW6002 did not change the proportion of the three RGC types during retinal development, but exerted a bidirectional effect on dendritic complexity of Type I and III RGCs and cell type-specifically altered their morphologies with decreased dendrite density of Type I, decreased the dendritic field area of Type II and III, increased dendrite density of Type III RGCs. …”

Image1_The adenosine A2A receptor antagonist KW6002 distinctly regulates retinal ganglion cell morphology during postnatal development and neonatal inflammation.TIF by Shisi Hu (14267858)

“…We found that the A_2AR antagonist KW6002 did not change the proportion of the three RGC types during retinal development, but exerted a bidirectional effect on dendritic complexity of Type I and III RGCs and cell type-specifically altered their morphologies with decreased dendrite density of Type I, decreased the dendritic field area of Type II and III, increased dendrite density of Type III RGCs. …”

RFR magnitudes as functions of the stimulus level, keeping the relative level of the previous stimulus as a parameter; <i>s</i> (silence)–no previous stimulus. by Vladimir V. Popov (5563067)

RFR magnitude as a function of time after stimulus level changes (“transient”) and steady state response magnitude to the same stimulus level. by Vladimir V. Popov (5563067)

“…The left column–records after level changes from 40-dB (A) to 10-dB (D) increase; the right panel–records from 40-dB (E) to 10-dB (H) decrease. …”

RD bandwidths. by Vivek Astvansh (14310090)

Chemical structures of protodioscin (A) and dioscin (B). by Najat Bouchmaa (13558816)

Elevated plasmablast levels as a feature of MCC. by Quyuan Tao (12261798)

Data_Sheet_1_Ribosomal Protein RPL10A Contributes to Early Plant Development and Abscisic Acid-Dependent Responses in Arabidopsis.pdf by Rocío Soledad Ramos (9604277)

“…We then examined protein function during seedling establishment and abscisic acid (ABA) response. Heterozygous rpl10A mutant plants show decreased ABA-sensitivity during seed germination, are impaired in early seedling and root development, and exhibit reduced ABA-inhibition of stomatal aperture under light conditions. …”

Table_1_Allium sativum: A potential natural compound for NAFLD prevention and treatment.DOCX by Parham Mardi (10320722)

“…Also, pooling data from case-control studies showed that A. sativum consumption decreases the odds of being diagnosed with NAFLD by 46% (OR = 0.538, 95%CI = 0.451–0.625).…”

Data Sheet 2_CD44 knockdown alters miRNA expression and their target genes in colon cancer.pdf by Diana Maltseva (11678641)

“…Introduction<p>Metastasis formation poses a significant challenge to oncologists, as it severely limits the survival of colorectal cancer (CRC) patients. …”

Data Sheet 4_CD44 knockdown alters miRNA expression and their target genes in colon cancer.pdf by Diana Maltseva (11678641)

“…Introduction<p>Metastasis formation poses a significant challenge to oncologists, as it severely limits the survival of colorectal cancer (CRC) patients. …”

Data Sheet 5_CD44 knockdown alters miRNA expression and their target genes in colon cancer.zip by Diana Maltseva (11678641)

“…Introduction<p>Metastasis formation poses a significant challenge to oncologists, as it severely limits the survival of colorectal cancer (CRC) patients. …”

Data Sheet 1_CD44 knockdown alters miRNA expression and their target genes in colon cancer.pdf by Diana Maltseva (11678641)

“…Introduction<p>Metastasis formation poses a significant challenge to oncologists, as it severely limits the survival of colorectal cancer (CRC) patients. …”

Data Sheet 3_CD44 knockdown alters miRNA expression and their target genes in colon cancer.pdf by Diana Maltseva (11678641)

“…Introduction<p>Metastasis formation poses a significant challenge to oncologists, as it severely limits the survival of colorectal cancer (CRC) patients. …”

The F595A homolog in JAK1, F636A, blocks constitutive activity of JAK1 V658F. by Alexandra Dusa (247246)

“…<p>Transient transfection in the JAK1-deficient U4C cell line indicates a decrease in the STAT3 transcriptional activity in the JAK1 F636A/V658F, as compared to JAK1 V658F.…”

Estimated trajectory path for <i>S</i>, <i>V</i>₁, <i>E</i>₁, <i>A</i>₁, <i>I</i>₁, and <i>R</i>₁ for the Delta variant. by Olusegun Michael Otunuga (13175869)

“…The reproduction number for the variant, using (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0271446#pone.0271446.e069" target="_blank">14</a>), was calculated to be 1.94.…”

HIV care budget increase and reduction in transmissions by ART initiation strategy and CD4 count at presentation to care, both after 10 years. by Eric N. Ouattara (6890174)

DataSheet_1_Apolipoprotein A-I levels in the survival of patients with colorectal cancer: a retrospective study.docx by Hailun Xie (10278446)

“…Each one-standard-deviation increase in ApoA-I level was related to a 12.0% decrease in PFS risk (hazard ratio [HR] 0.880; 95% confidence interval [CI], 0.801–0.968; P = 0.009) and an 11.2% decrease in OS risk (HR 0.888; 95%CI, 0.806–0.978; P = 0.015). …”